South Sudan has confirmed 42 yellow fever cases and 6 deaths in Yei River State, a case fatality rate of 14%. PandemicAlarm rates this event at 3/5 severity. The outbreak is concentrated along the borders with the Democratic Republic of Congo and Uganda, two countries with their own yellow fever risk and vaccination gaps. Cross-border transmission would escalate this situation significantly.
What is yellow fever?
Yellow fever is a hemorrhagic viral disease transmitted by Aedes mosquitoes. Most infections cause mild illness (fever, headache, nausea) that resolves within a week. But roughly 15% of symptomatic cases progress to a severe toxic phase: jaundice (the "yellow" in the name), liver failure, kidney failure, and hemorrhaging. Case fatality in the toxic phase runs 20-50%. No antiviral treatment exists. Care is entirely supportive.
The yellow fever vaccine is one of the most effective vaccines ever developed. A single dose provides lifelong immunity in 99% of recipients within 30 days. For a disease this lethal, a vaccine this effective should make elimination possible. Global supply is the obstacle.
Why is vaccine supply a problem?
Only four WHO-prequalified manufacturers produce yellow fever vaccine worldwide. Total annual production capacity sits at roughly 80-100 million doses in a good year, but demand during outbreak response campaigns regularly exceeds supply.
WHO's emergency response protocol now uses fractional dosing — one-fifth of a standard dose — during mass campaigns. A 2016 emergency vaccination campaign in DRC, Uganda, and Angola used fractional doses to stretch 17 million full doses into enough supply to vaccinate 30 million people. Fractional doses provide protection for at least 12 months and likely longer, though data on lifetime durability is still being collected.
South Sudan's routine vaccination coverage is among the lowest in the world. Years of civil conflict have disrupted immunization programs. Supply chain infrastructure barely functions outside Juba. Getting cold-chain vaccines to Yei River State, near the DRC border and far from the capital, is a logistical problem even without active conflict complicating access.
What's the cross-border risk?
Yei River State shares borders with DRC's Haut-Uele Province and Uganda's Moyo District. All three areas have Aedes mosquito populations capable of sustaining yellow fever transmission. Population movement across these borders is constant: trade, family connections, displacement from ongoing insecurity. A virus doesn't recognize national boundaries, and neither does a mosquito.
DRC has experienced recurrent yellow fever outbreaks over the past decade. Uganda's last confirmed outbreak was in 2020. Neither country has achieved the 80% vaccination coverage threshold WHO considers necessary for preventing urban outbreaks. If yellow fever reaches a densely populated urban center with low vaccination coverage, case numbers could multiply from dozens to thousands within weeks.
What should you watch?
Geographic spread beyond Yei River State is the key indicator. Yellow fever in rural communities with limited population density tends to produce contained outbreaks. Yellow fever in an urban area — Juba, Kampala, Kisangani — would be a different order of magnitude. Watch for case reports outside the current outbreak zone, WHO emergency stockpile releases, and any fractional dose campaign announcements. Track this outbreak on the PandemicAlarm map and check the regional risk breakdown for updated travel guidance to East Africa.